Local hospitals are grappling with a significant shortage of Carboplatin and Cisplatin, two vital cancer-treating drugs. The scarcity reached a critical point in May, necessitating some patients to switch treatments to avoid delays in care.
The shortage stemmed from the closure of a plant in India flagged for various issues by the FDA, leading to a disruption in the cancer drug supply chain, according to experts.
In response, Upstate University Hospital has implemented strategies to ensure continued patient care, according to CNY Central.
Patients who were receiving one drug that’s in short supply have been getting moved to others that are in better supply.
They’ve also placed backorders with suppliers, liaised directly with drug companies, and even formed partnerships with regional centers to share resources.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected].